Secretion of prednisolone into breast milk
Many drugs are secreted into breast milk (Knowles, 1965; Catz and Giacoia, 1972) but only a few in quantities sufficient to affect the suckling infant-for instance, thiouracil, bromides, alcohol, and ergot. Little is known of the secretion of steroids, perhaps because of the problems of estimating these compounds in milk. This communication reports measurements of the secretion of radioactive (tritium-labelled) prednisolone and its radioactive metabolites in the breast milk of seven healthy women. An oxidation technique was used to prepare the tritium in the milk in a suitable form for liquid scintillation counting.
Subjects and methods
Seven healthy lactating volunteers were chosen for the study. Three were mothers who had been lactating for several months and were about to wean their infants. Four were mothers, recently delivered, who had elected to bottle-feed their infants but who were willing to lactate for the duration of the study; lactation was well established before the study commenced. The study was sanctioned by the Ethics Committee of the Royal Free Hospital and permission for the radioactive dosage used was given by the Isotope Panel of the Medical Research Council. No infants went to the breast after the mothers had entered the study.
Each subject was given orally 5 mg prednisolone incorporating 10 ,uCi 3H-prednisolone. The radioactive prednisolone, supplied by the Radiochemical Centre, Amersham, was labelled at positions 1, 2, 4, and 6 of the steroid nucleus. The dose for each subject was dissolved in 5 ml ethanol and then added to 25 ml of orange juice. Each subject expressed milk with the assistance of a breast-pump at varying intervals over a period of about 48 hours after taking the radioactive dose. The times of expression were not rigidly controlled but were left to the convenience of the individual. In two subjects urine was collected for 48 hours.
Quadruplicate 0 5 ml aliquots of each milk sample were prepared for liquid scintillation counting by oxidation using a Packard Model 306 Sample Oxidiser (Packard Instrument Company, Illinois). Packard Combustaid 0 * 3 ml was added to each sample to ensure a sufficiently high temperature for complete combustion. The recovery obtained with this oxidation technique was found by experiment to be better than 98 %. The mean background (using polyethylene counting vials) was about 14 counts/min with a standard deviation of less than ±2 counts/min.
Results
The concentration of radioactivity in each sample of milk is shown in the Table. For each subject the highest level of radioactivity was recorded in the first sample obtained. The level then fell rapidly, typically reaching an approximate plateau after 24 to 36 hours (Fig.) 0 09±0 040% of administered radioactivity per litre of milk (mean ± SD). The mean total recovery of the radioactive dose in breast milk over the period of the study normalized to a milk volume of 1 litre was 0 -14% (range 0 * 07-0 23).
Urine was collected from two subjects (Nos. 3 and 5) for 48 hours. The total recoveries of the radioactive dose were 30 and 32% respectively.
Discussion
Only low levels of naturally occurring steroids have been found in human and cow's milk (Harkness and Darling, 1971) . Nevertheless, the secretion of pregnane-3a, 20,B-diol in breast milk is thought to contribute to prolonged neonatal jaundice either by inhibiting glucuronyl transferase 28  31  47  48  3  7  14  19  23  27  31  39  43   47  10  24  34  58  61  4  10  23  29  33  48   30  28  20  20  30  26  30  57  62  66  54  62  100  48  92  66  90  110  64  100  74  83  88  78  59  10  12  15  8  25  110  130  90  30  200  140   16  31  14  16  20  123  96  138  132  116 , 1964) or by inhibiting the secretion of bilirubin glucuronide from the liver (Hargreaves and Piper, 1971) . Studies on lactating rats given cortisone 20 mg/day showed a significant retardation of growth and development in the sucklings. Most of them died and the survivors weighed 50-60% less than the controls, had lustreless pelts, and greatly retarded sexual development (MercierParot, 1955) . Gynaecomastia has been reported in a male infant when his mother inadvertently doubled the dose of her oral contraceptives (Curtis, 1964) . Clinical side effects in infants who have been breast-fed by mothers receiving prednisolone have not been recorded but such mothers desiring to breast feed their babies may have been discouraged.
The secretion of 3H in human breast milk has previously been studied after the administration of labelled oral contraceptives. Pincus et al. (1966) found the recovery of radioactivity over a four-day period from administration of 3H-norethynodiol or 3H-ethynodiol diacetate was less than 0 * 15% of the administered dose. In contrast, Laumas et al.
(1967) found a mean recovery of I -1% over a fiveday period after administration of3H-norethynodiol. One possible reason for the difference between these results may have been the difficulties in preparing low-activity milk samples for liquid scintillation counting. Laumas et al. (1967) 
